• / Free eNewsletters & Magazine
  • / My Account
Home>Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders

Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders

3party Content

Tue, 22 Jul 2014

Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.